Reporting on supply chains
Read this section in the full bill →
This section appears in one version only, so there is nothing to compare yet.
Section 510(j)(3)(A) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360(j)(3)(A)) is amended— (1) by striking annually to the Secretary in the first sentence and inserting to the Secretary, once during the month of March each year and once during the month of September each year,; (2) by inserting, and the legal names of, and any additional information the Secretary may require, regarding suppliers of active pharmaceutical ingredients and intermediate and in-process materials such person used for the manufacture, preparation, propagation, compounding, or processing of such drug, and the amount of such drug manufactured, prepared, propagated, compounded, or processed using each such active pharmaceutical ingredient or intermediate or in-process material sourced from each such supplier before the period at the end of the first sentence; and (3) by inserting after the first sentence the following: In addition to the reporting required under the preceding sentence, each person who registers with the Secretary under this section with regard to a drug may voluntarily report on the information described in the preceding sentence, at such other times as the Secretary may specify..